Neville Rodie & Shaw Inc Zimmer Biomet Holdings, Inc. Transaction History

Neville Rodie & Shaw Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$110.76 - $143.18 $664 - $859	-6 Reduced 0.17%	3,494 $392,000
Q4 2020 Mar 04, 2021	SELL	$128.25 - $151.41 $292,410 - $345,214	-2,280 Reduced 39.45%	3,500 $539,000
Q3 2020 Oct 01, 2020	SELL	$113.59 - $141.68 $16,356 - $20,401	-144 Reduced 2.43%	5,780 $787,000
Q4 2019 Jan 08, 2020	SELL	$127.4 - $146.83 $8,918 - $10,278	-70 Reduced 1.17%	5,924 $886,000
Q3 2019 Oct 02, 2019	SELL	$113.33 - $138.46 $38,985 - $47,630	-344 Reduced 5.43%	5,994 $822,000
Q3 2018 Oct 09, 2018	SELL	$108.41 - $127.64 $4,444 - $5,233	-41 Reduced 0.64%	6,338 $833,000
Q3 2017 Oct 03, 2017	BUY	$106.92 - $117.79 $682,042 - $751,382	6,379	6,379 $747,000

1,080

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

Stay updated on Neville Rodie & Shaw Inc with notifications on news.